top of page

Prof Jacintha O'Sullivan on Esophageal Cancer

Updated: Apr 25, 2021

Professor Jacintha O'Sullivan explains her research ('Gold-drug: Targeting a novel dual inhibitor drug with gold nanoparticles for improving radiation response in oesophageal cancer) and the discovery of a novel drug which makes the tumour responsive to medication and will provide a more targeted treatment. Professor O'Sullivan also explains the impact that this research will have on those patients living with cancer.

Find out more about Prof O'Sullivan research here.


Commenting has been turned off.
bottom of page